Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01012180 · ClinicalTrials.gov registry record

Parents With Bipolar Disorder: Relationship of Adaptation to Own Illness With Risk Perception and Coping With Perceived Risk to a Child

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
266
Enrollment target

NCT01012180: Completed study, sponsored by National Human Genome Research Institute (NHGRI).

NCT01012180 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 266 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01012180 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
266 participants
Enrollment target

Study Summary

Background: * Bipolar disorder is a common mood disorder that affects 1% to 2% of the population. Individuals with bipolar disorder tend to have periods of mania that are characterized by extra energy, very poor judgment or unrealistic beliefs about their thoughts and abilities, and an inability to complete thoughts and tasks; as well as major depressive episodes. The range and frequency of symptoms in affected individuals can vary greatly. Most individuals have cyclical symptoms and spend more time in a normal mood state than in an overtly symptomatic state. * Relatives of individuals with bipolar disorder have an increased risk for bipolar disorder and other mood disorders. Currently, risk assessment for recurrence of a mood disorder is based on family and medical histories; genetic testing has not proved particularly useful to date for assessing risks of a mood disorder. * Despite its prevalence, there is limited research on coping with bipolar illness. No published studies have examined adaptation to living with bipolar disorder or risk for bipolar disorder. More specifically, though a positive family history is the most important known risk factor for bipolar disorder, there are no published studies about response to the threat of future illness onset in children, risk modification efforts undertaken by affected parents, or coping with the risk for illness in children. Objectives: * To examine parents appraisals of the impact and cause of bipolar disorder, and the association with their perceived risk for bipolar illness in their child and how they cope with their perception of risk to their child. * To assess whether parents adaptation to their own illness is associated with coping with perceived risk to their child. * To describe parents coping strategies related to perceived risk in their children. Eligibility: \- Men and women at least 18 years of age who have been diagnosed with bipolar disorder and who have at least one biological child (30 years of

Trial Details

FieldValue
Enrollment Target 266 participants
Start Date 2009-10-23
Est. Completion 2013-06-07

What the finished NCT01012180 record still lists

NCT01012180 is an observational study that tracks outcomes without assigning an intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT01012180 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01012180 about?

NCT01012180 is a clinical study titled "Parents With Bipolar Disorder: Relationship of Adaptation to Own Illness With Risk Perception and Coping With Perceived Risk to a Child". Background: * Bipolar disorder is a common mood disorder that affects 1% to 2% of the population. Individuals with bipolar disorder tend to have periods of mania that are characterized by extra energy, very poor judgment or unrealistic beliefs about their thoughts and abilities, and an inability to...

What is the current status of trial NCT01012180?

This trial is currently completed. The enrollment target is 266 participants. The study started on 2009-10-23. Estimated completion is 2013-06-07.

Who is sponsoring clinical trial NCT01012180?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05098652 · 266 participants · NA

    Coaching Dementia Caregivers to Master Care-Resistant Behavior

  • NCT06088277 · 266 participants · NA

    Texting to Reduce Human Immunodeficiency Virus (HIV) Risk

  • NCT06261814 · 266 participants · Phase 2

    Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors

  • NCT06312124 · 266 participants · NA

    A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01012180, the US trial registry maintained by the National Library of Medicine. NCT01012180 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.